Published in J Nutr on January 01, 1994
Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut (1998) 1.96
A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One (2012) 1.86
Functional analysis of colonic bacterial metabolism: relevant to health? Am J Physiol Gastrointest Liver Physiol (2011) 1.21
Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis (2009) 1.12
Probiotics and medical nutrition therapy. Nutr Clin Care (2004) 1.10
Metabolic activities of ginseng and its constituents, ginsenoside rb1 and rg1, by human intestinal microflora. J Ginseng Res (2011) 1.08
Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol (2009) 0.92
Submerged fermentation of Lactobacillus rhamnosus YS9 for γ-aminobutyric acid (GABA) production. Braz J Microbiol (2013) 0.85
Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci (2010) 0.83
Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. Int J Nephrol (2012) 0.82
SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrol (2014) 0.81
The effect of drinking milk containing conjugated linoleic acid on fecal microbiological profile, enzymatic activity, and fecal characteristics in humans. Nutr J (2007) 0.78
Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment. Glob Adv Health Med (2014) 0.77
p-Cresyl Sulfate. Toxins (Basel) (2017) 0.77
A non-dairy probiotic's (poi) influence on changing the gastrointestinal tract's microflora environment. Altern Ther Health Med (2005) 0.76
Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent. Biomed Res Int (2013) 0.75
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 3.61
Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol (1999) 2.70
Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics (1999) 2.45
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther (2007) 2.38
Probiotics: effects on immunity. Am J Clin Nutr (2001) 2.10
Vitamin B-12 status of long-term adherents of a strict uncooked vegan diet ("living food diet") is compromised. J Nutr (1995) 2.08
Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00
The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in Europeans. Ann Hum Genet (2003) 1.96
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92
Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med (1990) 1.90
Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr (1997) 1.80
Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy (2005) 1.75
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J (1997) 1.71
Sevoflurane-nitrous oxide or halothane-nitrous oxide for paediatric bronchoscopy and gastroscopy. Br J Anaesth (1996) 1.68
Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol (1997) 1.65
Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet (2006) 1.64
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther (2005) 1.64
Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol (2002) 1.62
Antioxidant status in vegetarians versus omnivores. Nutrition (2000) 1.58
Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med (1990) 1.54
Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol (1998) 1.52
Nutritional modulation of exercise-induced immunodepression in athletes: a systematic review and meta-analysis. Eur J Clin Nutr (2006) 1.51
Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy (2007) 1.49
Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy (2001) 1.47
Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol (1995) 1.46
Probiotics: a role in the treatment of intestinal infection and inflammation? Gut (2002) 1.46
Probiotics demonstrating efficacy in clinical settings. Clin Infect Dis (2001) 1.46
An uncooked vegan diet shifts the profile of human fecal microflora: computerized analysis of direct stool sample gas-liquid chromatography profiles of bacterial cellular fatty acids. Appl Environ Microbiol (1992) 1.44
Surface binding of aflatoxin B(1) by lactic acid bacteria. Appl Environ Microbiol (2001) 1.37
Quality assurance criteria for probiotic bacteria. Am J Clin Nutr (2001) 1.37
Back and hip extensor activities during trunk flexion/extension: effects of low back pain and rehabilitation. Arch Phys Med Rehabil (2000) 1.36
Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr (1999) 1.36
The efficacy of active rehabilitation in chronic low back pain. Effect on pain intensity, self-experienced disability, and lumbar fatigability. Spine (Phila Pa 1976) (1999) 1.34
Paediatric out-of-hospital cardiac arrests--epidemiology and outcome. Resuscitation (1995) 1.33
Back and hip extensor fatigability in chronic low back pain patients and controls. Arch Phys Med Rehabil (1998) 1.33
Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol (2001) 1.30
Probiotics reduce the prevalence of oral candida in the elderly--a randomized controlled trial. J Dent Res (2007) 1.30
Double-blind evaluation of a lignocaine-prilocaine cream (EMLA) in children. Effect on the pain associated with venous cannulation. Br J Anaesth (1986) 1.29
Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci (1994) 1.27
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther (2005) 1.25
Indoor aerosols: from personal exposure to risk assessment. Indoor Air (2013) 1.24
Shifting from a conventional diet to an uncooked vegan diet reversibly alters fecal hydrolytic activities in humans. J Nutr (1992) 1.23
Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol (2000) 1.21
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol (2007) 1.20
Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol (2008) 1.19
Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol (2001) 1.19
Fully rectified, integrated, band (FRIB-) EMG analysis in quantifying muscle activity. Development of a new field equipment. Acta Physiol Scand Suppl (1984) 1.19
Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy (1998) 1.18
Impact of regular relaxation training and psychosocial working factors on neck-shoulder tension and absenteeism in hospital cleaners. J Occup Med (1993) 1.17
Utstein style reporting of in-hospital paediatric cardiopulmonary resuscitation. Resuscitation (2000) 1.16
Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children? Can J Anaesth (1988) 1.15
Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr (2010) 1.14
Comparison of buprenorphine with morphine in the treatment of postoperative pain in children. Anesth Analg (1988) 1.14
Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum. J Food Prot (2000) 1.14
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer (2007) 1.13
Activation of microsomal UDP glucuronyltransferase by phospholipases. Chem Biol Interact (1971) 1.12
Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J Food Prot (1998) 1.11
Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy (2008) 1.10
A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia (2011) 1.10
Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol (2003) 1.09
Rye bread decreases postprandial insulin response but does not alter glucose response in healthy Finnish subjects. Eur J Clin Nutr (1999) 1.09
Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol (1985) (1992) 1.09
Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07
Ability of dairy strains of lactic acid bacteria to bind aflatoxin M1 in a food model. J Food Prot (2000) 1.07
Measurement of pain in children with self-reporting and behavioral assessment. Clin Pharmacol Ther (1987) 1.07
Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters. Am J Clin Nutr (1999) 1.07
Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain of children. Br J Anaesth (1988) 1.06
Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol (2001) 1.06
Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol (1997) 1.06
The allergy epidemic extends beyond the past few decades. Clin Exp Allergy (2004) 1.06
Lactose intolerance. J Am Coll Nutr (2000) 1.06
Aflatoxin B1 binding by dairy strains of lactic acid bacteria and bifidobacteria. J Dairy Sci (2001) 1.04
Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol (2004) 1.03
Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol (1988) 1.03
Removal of common Fusarium toxins in vitro by strains of Lactobacillus and Propionibacterium. Food Addit Contam (2002) 1.02
Gut bacteria and health foods--the European perspective. Int J Food Microbiol (2002) 1.02
A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation. Eur J Clin Nutr (2006) 1.00
Exercise-induced oxidative stress: glutathione supplementation and deficiency. J Appl Physiol (1985) (1994) 0.99
Lactase haplotype frequencies in Caucasians: association with the lactase persistence/non-persistence polymorphism. Ann Hum Genet (1998) 0.99
Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. J Pharmacol Exp Ther (2001) 0.99
Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther (2007) 0.98
Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. J Dairy Sci (2001) 0.98
Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr (2010) 0.98
Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int J Food Microbiol (2001) 0.97
Role of irritable bowel syndrome in subjective lactose intolerance. Am J Clin Nutr (1998) 0.97
Disc herniation-related back pain impairs feed-forward control of paraspinal muscles. Spine (Phila Pa 1976) (2001) 0.96
Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surface properties of lactobacilli. Appl Environ Microbiol (2004) 0.96
Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol (2001) 0.96
Microbial interactions to intestinal mucosal models. Methods Enzymol (2001) 0.96